Related Experiment Video

Updated: Mar 26, 2026

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
08:00

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

Published on: July 10, 2019

6.6K

Increase in phosphorylation of PDK1 and cell survival after acute spinal cord injury

Yi Zhong1, Ye Huang, Jianhua Cao

  • 1Department of Orthopaedics, the Second Affiliated Hospital, Nanjing Medical University, Nanjing 210011, China.

Journal of the Neurological Sciences
|July 4, 2012
PubMed

Insights

3-Phosphoinositide-dependent protein kinase-1 (PDK1) phosphorylation increases after spinal cord injury (SCI) in rats, primarily in neurons and oligodendrocytes. This suggests PDK1 may be a target for neuroprotection and functional repair in CNS injury.

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Biochemistry

Background:

  • 3-Phosphoinositide-dependent protein kinase-1 (PDK1) is crucial for cell signaling, regulating metabolism, growth, proliferation, and survival.
  • The specific role of PDK1 and its phosphorylation in central nervous system (CNS) injury, particularly spinal cord injury (SCI), is not well understood.

Purpose of the Study:

  • To investigate the expression and localization of phosphorylated PDK1 (p-PDK1s241) in an acute rat SCI model.
  • To explore the potential involvement of PDK1 phosphorylation in CNS injury and repair processes.

Main Methods:

  • An acute spinal cord injury (SCI) model was established in adult rats.
  • Western blot and immunohistochemistry were used to detect the expression and localization of p-PDK1s241.
  • Double immunofluorescence labeling was employed to identify specific cell types expressing p-PDK1s241 and its co-localization with active caspase-3.

Main Results:

  • p-PDK1s241 expression increased significantly 6-12 hours post-SCI, returning to baseline by 3 days.
  • p-PDK1s241 showed dynamic subcellular localization changes (nucleus and cytoplasm) in neurons and glial cells.
  • p-PDK1s241 was primarily localized in neurons and oligodendrocytes, with potential expression in other glial cells near the injury epicenter.
  • p-PDK1s241 and active caspase-3 exhibited distinct cellular distributions, suggesting a role independent of apoptosis.

Conclusions:

  • PDK1 phosphorylation is upregulated following acute SCI in a time-dependent manner.
  • The localization of p-PDK1s241 in neurons and oligodendrocytes suggests a role in CNS injury response.
  • PDK1 phosphorylation may be linked to cell survival mechanisms, positioning PDK1 as a potential therapeutic target for neuroprotection and functional recovery after SCI.

More Related Videos

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

9.2K
Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury10:56

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Published on: December 17, 2014

13.6K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K